The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-Methyl-cyclopropyl)-4-(8-methyl-nona-1,5,7-trienyl)-4,5-dihydro-thiazole ID: ALA88531
PubChem CID: 44323027
Max Phase: Preclinical
Molecular Formula: C17H25NS
Molecular Weight: 275.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)=C/C=C/CC/C=C\[C@@H]1CSC([C@@H]2C[C@@H]2C)=N1
Standard InChI: InChI=1S/C17H25NS/c1-13(2)9-7-5-4-6-8-10-15-12-19-17(18-15)16-11-14(16)3/h5,7-10,14-16H,4,6,11-12H2,1-3H3/b7-5+,10-8-/t14-,15+,16+/m0/s1
Standard InChI Key: ABDZABIBSBAXPA-XHMZZEABSA-N
Molfile:
RDKit 2D
21 22 0 0 1 0 0 0 0 0999 V2000
9.5917 -4.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0417 -5.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4917 -6.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7667 -4.8375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8667 -5.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8417 -4.0542 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5125 -4.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9167 -5.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -5.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1000 -5.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7250 -3.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1875 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1875 -5.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9000 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5542 -5.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6292 -4.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4542 -4.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6542 -6.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 -5.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4167 -6.0792 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
9.4417 -6.0875 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 2 0
5 2 1 0
6 1 1 0
7 4 1 0
8 9 1 0
9 13 2 0
10 8 2 0
7 11 1 6
12 6 1 0
13 16 1 0
14 11 2 0
15 5 1 0
16 17 1 0
17 14 1 0
18 10 1 0
19 10 1 0
5 20 1 6
2 21 1 6
7 12 1 0
3 5 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 275.46Molecular Weight (Monoisotopic): 275.1708AlogP: 5.02#Rotatable Bonds: 6Polar Surface Area: 12.36Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.35CX LogP: 4.91CX LogD: 4.91Aromatic Rings: ┄Heavy Atoms: 19QED Weighted: 0.38Np Likeness Score: 2.45
References 1. Wipf P, Reeves JT, Balachandran R, Day BW.. (2002) Synthesis and biological evaluation of structurally highly modified analogues of the antimitotic natural product curacin A., 45 (9): [PMID:11960501 ] [10.1021/jm0105171 ] 2. Nishikawa A, Shirai R, Koiso Y, Hashimoto Y, Iwasaki S. (1997) Design and synthesis of curacin a analogs with varied side chain structures, 7 (20): [10.1016/S0960-894X(97)10055-5 ]